Clinical trial
Buprenorphine and Integrated HIV Care Evaluation
NCT00124358 · The New York Academy of Medicine, Other · Unknown status
Key facts
| NCT number | NCT00124358 |
|---|---|
| Title | Buprenorphine and Integrated HIV Care Evaluation |
| Official title | An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings |
| Lead sponsor | The New York Academy of Medicine, Other |
| Collaborators | Health Resources and Services Administration (HRSA) U.S. Fed El Rio Santa Cruz Neighborhood Health Center Organization to Achieve Solutions in Substance Abuse (OASIS) Oregon Health and Science… |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Opioid-Related Disorders, HIV Infections, AIDS |
| Intervention type | Behavioral, Drug |
| Interventions | Buprenorphine, Integrated HIV care and office-based opioid dependence treatment |
| Enrollment | 1,350 |
| Start date | Aug 1, 2005 |
| Completion | Dec 1, 2008 |
| First posted | Jul 27, 2005 |
| Last update posted | Mar 27, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- 10–99 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: